Recent advancements in diabetes treatment have brought forth a new generation of therapies known as GLP-1 receptor agonists. These compounds work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a hormone https://socialmediainuk.com/story25228880/glp-1-receptor-agonists-retaglutide-retatrutide-and-tirzepatide